la
cross
viru
lacv
famili
bunyavirida
mosquitoborn
pathogen
endem
unit
state
lacv
genom
consist
three
singlestrand
negativesens
rna
genom
segment
design
small
medium
larg
l
segment
encod
two
protein
overlap
read
frame
nucleoprotein
n
nonstructur
protein
nss
suppress
type
interferon
ifn
mammal
host
segment
encod
singl
polyprotein
polyprotein
posttransl
process
two
glycoprotein
gn
gc
nonstructur
protein
nsm
gn
gc
major
protein
neutral
antibodi
direct
l
segment
encod
singl
open
read
frame
rnadepend
rna
polymeras
l
viru
transmit
hardwood
forest
dwell
mosquito
aed
triseriatu
breed
tree
hole
outdoor
contain
ae
triseriatu
feed
eastern
chipmunk
tamia
striatu
grinseu
eastern
gray
squirrel
sciuru
carolinensi
serv
amplifi
host
lacv
interestingli
viru
maintain
mosquito
popul
absenc
vertebr
host
transovari
vertic
transmiss
thu
allow
viru
overwint
mosquito
egg
recent
lacv
isol
natur
infect
nonn
aed
albopictu
mosquito
infect
ae
albopictu
may
repres
shift
viru
ecolog
increas
possibl
gener
new
reassort
lacv
first
identifi
human
pathogen
isol
yearold
girl
minnesota
suffer
meningoenceph
later
die
la
cross
wisconsin
human
major
infect
mild
attribut
flu
summer
cold
estim
infect
annual
seriou
case
report
isol
viru
rare
made
postmortem
brain
tissu
collect
two
isol
nonfat
lacv
case
collect
one
brain
biopsi
child
one
cerebrospin
fluid
histopatholog
chang
two
human
case
one
one
characterist
viral
enceph
inflammatori
lesion
consist
infiltr
mononuclear
leukocyt
either
diffus
microgli
nodul
largest
inflammatori
foci
observ
cerebr
cortex
includ
frontal
pariet
tempor
lobe
foci
could
also
found
basal
ganglion
pon
two
case
lack
inflammatori
lesion
posterior
occipit
cortex
cerebr
white
matter
cerebellum
medulla
spinal
cord
brain
biopsi
nonfat
lacv
infect
contain
area
perivascular
mononuclear
cuf
focal
aggreg
mononuclear
microglia
cell
rtpcr
analysi
neural
tissu
case
could
detect
viral
rna
cerebr
cortex
medulla
cerebellum
spinal
cord
basal
ganglion
tempor
lobe
children
adult
sever
lacv
enceph
clinic
mimic
herp
simplex
viru
enceph
fever
focal
sign
possibl
progress
coma
confirmatori
diagnosi
made
rtpcr
cerebrospin
fluid
exclud
herp
simplex
viru
fluoresc
stain
lacv
antigen
brain
biopsi
section
children
recov
sever
la
cross
enceph
may
significantli
lower
iq
score
expect
high
preval
test
attentiondeficithyperact
disord
seizur
disord
also
common
survivor
project
lifelong
econom
cost
associ
neurolog
sequela
rang
per
case
current
vaccin
specif
antivir
treatment
avail
could
serv
reduc
clinic
econom
impact
common
infect
although
evid
lacv
infect
report
sever
speci
limit
research
done
understand
lacv
pathogenesi
natur
host
experiment
rodent
lacv
administ
subcutan
suckl
mice
first
replic
muscl
viremia
develop
viru
invad
brain
across
vascular
endotheli
cell
viru
replic
muscl
confirm
immunohistochem
ihc
stain
predomin
cell
type
infect
cn
neuron
virul
lacv
mice
decreas
increas
age
similar
human
caus
cn
diseas
predominantli
pediatr
popul
initi
step
establish
anim
model
use
vaccin
develop
human
sought
better
character
tissu
tropism
lacv
mice
identifi
tissu
support
lacv
replic
peripher
inocul
previous
describ
swiss
webster
mice
suitabl
character
lacv
infect
birth
age
inocul
old
swiss
webster
mice
either
viru
intraperiton
twenti
tissu
individu
collect
six
consecut
day
process
viru
titrat
immunohistochem
stain
histopatholog
studi
sinc
experiment
infect
nonhuman
primat
lacv
report
also
sought
determin
rhesu
monkey
suscept
lacv
infect
rhesu
monkey
chosen
sinc
suscept
varieti
neurotrop
arbovirus
includ
flavivirus
studi
rhesu
monkey
infect
intramuscularli
subcutan
mosquito
human
isol
lacv
two
isol
use
sinc
preliminari
genom
sequenc
analysi
indic
host
specif
differ
lacv
isol
human
mosquito
lacv
found
highli
infecti
rhesu
monkey
infect
result
viremia
diseas
signific
chang
blood
chemistri
cell
count
howev
high
titer
neutral
antibodi
develop
monkey
indic
rhesu
monkey
although
optim
use
studi
infect
immunogen
lacv
vaccin
candid
previou
evalu
lacv
suckl
mice
reveal
first
replic
striat
muscl
cell
seed
blood
next
invad
cn
replic
neuron
develop
rodent
model
live
attenu
lacv
vaccin
develop
program
sought
character
lacv
infect
outbr
weanl
mice
rather
suckl
mice
sinc
older
mice
use
studi
level
attenu
immunogen
lacv
vaccin
candid
identifi
key
step
pathogenesi
lacv
weanl
mice
evalu
lacv
tissu
tropism
peripher
inocul
wildtyp
viru
sought
identifi
tissu
viru
replic
effici
weanl
swiss
webster
mice
daysold
inocul
intraperiton
pfu
tissu
indic
figur
collect
mice
per
day
day
post
inocul
follow
inocul
either
dose
viru
could
first
detect
tissu
near
inocul
site
inguin
lymph
node
spleen
ovariesuteru
viru
detect
serum
day
rare
subsequ
day
even
moribund
mice
day
three
viru
distribut
widespread
could
found
major
tissu
sampl
albeit
low
level
titer
rare
exceed
found
serum
highest
viru
titer
detect
present
nasal
turbin
brain
spinal
cord
respiratori
tissu
includ
lung
nasal
turbin
contain
viru
follow
inocul
begin
day
respect
cn
infect
appear
follow
respiratori
tissu
infect
viru
present
brain
day
infect
day
infect
either
viru
dose
infect
appear
earli
lymph
node
major
organ
subsequ
infect
upper
respiratori
tract
nasal
turbin
follow
infect
brain
eventu
spinal
cord
day
six
mice
began
succumb
infect
high
dose
group
show
sign
paralysi
wherea
mice
low
dose
group
fail
show
clinic
sign
time
would
succumb
later
infect
result
indic
lacv
replic
low
moder
level
peripher
tissu
weanl
mice
nasal
turbin
rather
striat
muscl
major
site
replic
sinc
lacv
replic
high
titer
nasal
turbin
sought
determin
intranas
inocul
mice
lacv
could
lead
infect
threeweekold
swiss
webster
weanl
mice
n
inocul
intranas
volum
intraperiton
ip
volum
serial
dilut
infecti
dose
determin
clinic
diseas
serv
surrog
lethal
mice
promptli
euthan
prior
succumb
lacv
diseas
group
clinic
diseas
first
note
day
figur
twenti
day
postinocul
determin
surviv
mice
test
develop
neutral
antibodi
respons
determin
titer
mice
consid
infect
either
develop
clinic
diseas
serum
neutral
antibodi
titer
similar
ip
group
pfu
respect
follow
ip
inject
agreement
previou
experi
titer
pfu
ip
rout
respect
slightli
lower
titer
indic
lacv
caus
subclinc
infect
weanl
mice
low
dose
character
lacv
infect
weanl
mice
addit
group
inocul
intraperiton
select
tissu
serum
muscl
nasal
turbin
brain
spinal
cord
collect
viru
quantit
n
daili
six
day
confirm
titer
found
figur
histopatholog
immunohistochem
ihc
examin
n
daili
six
day
data
summar
tabl
figur
viru
titer
nasal
turbin
brain
spinal
cord
muscl
serum
agreement
find
figur
data
shown
histopatholog
lesion
brain
includ
area
olfactori
bulb
cerebr
cortex
thalamu
hippocampu
medulla
oblongata
spinal
cord
includ
perivascular
cuf
figur
neuron
degener
figur
necrosi
either
singl
cell
small
foci
apoptosi
infiltr
lymphocyt
macrophag
figur
extens
lesion
occur
medulla
oblongata
associ
perivascular
cuf
histopatholog
chang
minim
outsid
cn
spleen
lymphoid
atrophi
observ
day
postinfect
plasmacytosi
spleen
observ
day
area
necrosi
observ
day
myeloid
hyperplasia
day
histopatholog
chang
observ
respiratori
nasal
epithelium
muscl
upper
rear
limb
determin
locat
cell
express
viral
antigen
tissu
immunostain
la
cross
viru
antigen
viral
antigen
observ
nasal
turbin
muscl
spleen
pancrea
howev
viral
antigen
detect
olfactori
bulb
brain
thalamu
cerebrum
medulla
oblongata
spinal
cord
day
viral
antigen
could
detect
sampl
brain
region
greater
number
cell
region
posit
viral
antigen
overt
histolog
lesion
mild
perivascular
cuf
seen
area
singl
cell
necrosi
seen
area
stain
posit
viral
antigen
time
later
day
olfactori
bulb
extens
involv
figur
although
viral
antigen
detect
section
underli
nasal
epithelium
viral
antigen
could
detect
brain
tissu
mice
day
small
foci
antigen
seen
spinal
cord
one
mous
suggest
brain
infect
proce
spinal
cord
infect
day
viral
infect
cn
widespread
extens
throughout
region
brain
spinal
cord
figur
neuron
main
cell
express
viral
antigen
support
glia
also
appear
posit
figur
singl
cell
necrosi
focal
necrosi
one
cell
apoptot
bodi
promin
throughout
lesion
figur
apoptot
bodi
stain
posit
tunel
stain
figur
degen
neuron
chang
also
commonli
seen
includ
nuclear
vacuol
cell
shrinkag
figur
identifi
cell
infiltr
moribund
mous
brain
section
immunostain
use
antimacrophag
antibodi
cell
macrophag
seen
perivascular
locat
area
neuron
lesion
figur
within
grey
matter
spinal
cord
small
perivascular
cuff
lymphocyt
degen
neuron
viral
antigen
express
numer
neuron
figur
day
mice
abund
viral
antigen
cervic
thorac
region
spinal
cord
one
mous
viral
antigen
lumbar
spinal
cord
support
observ
infect
travel
caudal
brain
spinal
cord
develop
nonhuman
primat
model
lacv
infect
pathogenesi
studi
test
futur
vaccin
candid
rhesu
monkey
inocul
pfu
biolog
clone
termin
dilut
human
mosquito
lacv
ill
observ
follow
viru
administr
viru
detect
time
serum
sampl
tabl
viru
present
low
titer
lymph
node
day
howev
viru
replic
tissu
could
identifi
ihc
stain
despit
low
level
absenc
viremia
highli
restrict
replic
tissu
sampl
monkey
develop
neutral
antibodi
respons
first
detect
day
indic
monkey
infect
twentyeight
day
inocul
neutral
antibodi
titer
group
rang
tabl
lowlevel
crossreact
antibodi
present
two
monkey
dboh
start
experi
boost
antibodi
titer
monkey
observ
compar
monkey
suggest
experiment
lacv
infect
primari
infect
complet
blood
count
cbc
differenti
blood
chemistri
analyz
blood
collect
sinc
lacv
infect
monkey
asymptomat
also
sinc
differ
four
viru
group
indic
tabl
observ
cbc
blood
chemistri
data
averag
anim
detect
chang
blood
valu
cours
infect
tabl
day
specif
paramet
valu
signific
number
monkey
greater
standard
deviat
normal
appear
box
tabl
mean
valu
test
shown
day
major
monkey
experienc
slight
anemia
may
part
associ
overnight
fast
prepar
anesthesia
prior
blood
collect
analysi
suggest
infect
major
organ
liver
minim
absent
estim
minimum
dose
requir
infect
monkey
rhesu
monkey
inocul
pfu
subcutan
blood
collect
day
serum
neutral
antibodi
titer
determin
mean
neutral
antibodi
titer
pfu
dose
group
respect
monkey
seroconvert
day
tabl
thu
lacv
highli
infecti
rhesu
monkey
even
dose
pfu
result
induct
high
level
neutral
antibodi
howev
lacv
infect
result
identifi
clinic
abnorm
group
monkey
initi
step
develop
live
attenu
lacv
vaccin
sought
better
character
lacv
infect
weanl
mice
age
mice
use
evalu
level
attenu
immunogen
candid
vaccin
virus
previou
lacv
pathogenesi
studi
suckl
mice
inocul
subcutan
mosquito
isol
lacv
demonstr
viral
antigen
detect
cytoplasm
striat
muscl
interscapular
brown
fat
endotheli
smooth
muscl
cell
small
arteri
vein
viru
first
detect
brain
confin
cerebr
vascular
endotheli
cell
later
spread
neuron
author
suggest
late
infect
dorsal
rout
ganglion
indic
viru
penetr
cn
via
nerv
rather
vascular
endotheli
cell
previou
model
therefor
suggest
viru
first
replic
muscl
cell
lead
develop
viremia
subsequ
hematogen
spread
cn
sought
present
studi
examin
pattern
infect
also
occur
weanl
mice
weanl
mice
inocul
intraperiton
lacv
viru
first
detect
day
tissu
near
inocul
site
either
dose
viru
longer
detect
day
tissu
suggest
rapidli
clear
innat
immun
system
interestingli
viru
detect
muscl
tissu
day
post
inocul
clearli
preferenti
infect
tissu
rather
outsid
cn
viru
replic
highest
titer
nasal
turbin
appear
spread
site
brain
immunohistochem
stain
nasal
turbin
tissu
sensit
enough
identifi
lacv
infect
cell
thought
lacv
may
gain
access
cn
via
cell
nasal
turbin
suggest
offer
caveat
respiratori
epitheli
cell
could
also
infect
magnitud
infect
could
detect
ihc
stain
travel
nasal
olfactori
epithelium
olfactori
bulb
viru
would
follow
olfactori
neuron
brain
infect
first
detect
rostral
section
brain
although
viru
replic
nasal
turbin
tissu
detect
unabl
identifi
cell
infect
virus
vesicular
stomat
viru
rabi
viru
mous
hepat
viru
borna
diseas
viru
pseudorabi
viru
herp
simplex
viru
demonstr
enter
mous
cn
via
olfactori
neuron
import
note
mice
test
detect
viru
within
brain
without
detect
viru
nasal
caviti
individu
data
shown
suggest
one
rout
might
use
gain
access
cn
surpris
abil
viru
infect
intranas
found
almost
ident
either
rout
inocul
kinet
develop
clinic
diseas
occur
follow
intranas
administr
viru
similar
viru
given
ip
find
lacv
abl
infect
effici
via
nasal
rout
possibl
implic
ecolog
viru
possibl
infecti
viru
present
water
collect
contain
aed
mosquito
larva
eg
tree
hole
sinc
viru
shown
transmit
infect
mosquito
larva
via
egg
mammalian
host
drink
water
would
intak
fluid
might
contain
free
viru
lyse
larva
infect
larva
either
could
initi
infect
mammalian
host
thu
exposur
water
could
lead
altern
rout
infect
natur
host
ie
oralnas
rout
addit
vectorbourn
rout
hypothesi
need
confirm
experiment
remain
interest
possibl
cn
weanl
mous
lacv
infect
predominantli
neuron
microgli
cell
also
infect
spread
rostral
caudal
direct
eventu
reach
lumbar
spinal
region
mice
human
viru
detect
cerebr
cortex
howev
infect
appear
widespread
mous
cn
viru
detect
medulla
oblongata
cerebellum
thalamu
olfactori
bulb
region
spinal
cord
viru
use
studi
isol
passag
twice
mosquito
cell
previous
adapt
growth
mous
neural
tissu
one
surpris
differ
human
mous
infect
detect
viru
replic
ihc
develop
lesion
mous
spinal
cord
taken
togeth
data
suggest
weanl
mice
viru
first
replic
peripheri
near
inocul
site
infect
quickli
control
viru
dissemin
like
via
blood
nasal
turbin
detect
viru
lesion
first
rostral
brain
suggest
viru
may
util
olfactori
neuron
gain
access
cn
differ
find
studi
previou
work
may
result
differ
viru
strain
mosquito
vs
neurovirul
human
isol
mous
strain
outbr
white
vs
swiss
webster
mous
age
suckl
vs
weanl
inocul
rout
subcutan
vs
intraperiton
dose
vs
although
sequenc
data
avail
strain
use
previou
mous
pathogenesi
work
known
viru
mosquito
isol
directli
link
human
diseas
human
major
infect
asymptomat
children
hospit
sever
diseas
present
fever
headach
vomit
disorient
seizur
elev
peripher
whitecel
count
like
major
human
infect
rhesu
monkey
current
studi
experienc
subclin
infect
without
develop
system
diseas
neurolog
symptom
much
greater
number
monkey
would
probabl
need
test
detect
neurolog
symptom
peripher
inocul
nevertheless
monkey
infect
lacv
develop
neutral
antibodi
respons
even
inocul
littl
pfu
futur
work
includ
intracerebr
inocul
rhesu
monkey
determin
lacv
neurovirul
speci
wait
vaccin
candid
identifi
still
unclear
mani
human
lacv
infect
remain
asymptomat
mous
model
infect
viru
result
delay
cn
infect
compar
mice
receiv
mice
abl
control
viru
infect
dose
develop
strong
neutral
antibodi
respons
lacv
human
unknown
human
exposur
limit
small
dose
viru
may
effect
control
immun
system
cn
infect
may
avert
like
mous
model
individu
expos
greater
dose
viru
viru
growth
may
outpac
control
mechan
lead
cn
infect
support
role
immun
control
affect
human
diseas
outcom
shown
individu
resid
endem
area
major
histocompat
complex
molecul
cytotox
lymphocyt
greater
rel
risk
develop
enceph
infect
rel
risk
p
infect
individu
lower
rel
risk
develop
seizur
rel
risk
p
weanl
swiss
webster
mice
similar
indic
infect
lead
lethal
outcom
age
lacv
first
replic
tissu
near
inocul
site
enter
blood
stream
infect
nasal
turbin
gain
access
cn
presum
via
olfactori
neuron
model
use
identifi
attenu
vaccin
candid
defici
abil
dissemin
site
inocul
replic
high
titer
nasal
turbin
establish
infect
mous
cn
cn
infect
mice
appear
widespread
describ
human
infect
brain
spinal
cord
lacv
highli
infecti
ip
rout
suggest
infect
natur
mammalian
host
chipmunk
squirrel
might
occur
oralintranas
rout
addit
bite
infect
mosquito
rhesu
monkey
lacv
highli
infecti
littl
pfu
result
develop
neutral
antibodi
clinic
diseas
observ
dose
test
suggest
rhesu
monkey
use
studi
infect
immunogen
live
attenu
viru
vaccin
candid
limit
use
evalu
level
attenu
cell
aed
albopictu
mosquito
larva
maintain
earl
mem
supplement
fetal
bovin
serum
hyclon
mm
lglutamin
invitrogen
mm
nonessenti
amino
acid
vero
cell
african
green
monkey
kidney
maintain
medium
invitrogen
supplement
mm
lglutamin
invitrogen
isol
postmortem
brain
tissu
collect
minnesota
patient
hospit
la
cross
wisconsin
passag
two
time
cell
isol
mosquito
collect
north
carolina
passag
mous
brain
three
time
vero
cell
isol
postmortem
brain
tissu
collect
wisconsin
passag
mous
brain
twice
cell
vero
cell
biolog
clone
gener
termin
dilut
vero
cell
cultur
passag
histori
complet
genom
sequenc
stock
use
paper
previous
publish
weanl
swiss
webster
mice
tacon
farm
germantown
ny
inocul
dilut
media
invitrogen
intraperiton
volum
intranas
volum
isofluoran
anesthesia
mice
observ
daili
day
clinic
diseas
includ
tremor
seizur
limb
paralysi
moribund
mice
promptli
euthan
serum
collect
day
inocul
determin
presenc
titer
neutral
antibodi
replic
lacv
viru
evalu
weanl
femal
swiss
webster
mice
tacon
farm
germantown
ny
anim
experi
carri
accord
regul
guidelin
nation
institut
health
swiss
webster
mice
inocul
ip
volum
tissu
indic
tabl
collect
individu
mice
per
day
day
dose
viru
weigh
homogen
spg
buffer
final
concentr
mm
sucros
mm
lglutam
acid
mm
dibas
potassium
phosphat
ph
homogen
centrifug
minut
rpm
remov
cell
debri
aliquot
frozen
viru
quantit
perform
mice
care
observ
twice
daili
clinic
diseas
includ
tremor
limb
paralysi
mice
exhibit
clinic
diseas
promptli
euthan
monolay
cultur
vero
cell
grown
plate
infect
duplic
tenfold
serial
dilut
tissu
homogen
cell
overlay
optimem
invitrogen
supplement
methylcellulos
fb
amphotericin
b
ciprofloxicin
five
day
infect
overlay
remov
cell
wash
twice
pb
cell
fix
stain
minut
crystal
violet
solut
viru
plaqu
enumer
tissu
titer
express
mean
pfug
tissu
weanl
swiss
webster
mice
inocul
intraperiton
tissu
collect
six
consecut
day
viru
titrat
n
patholog
n
per
day
viru
titrat
perform
confirm
previou
viru
kinet
tissu
collect
patholog
fix
neutral
buffer
formalin
nbf
minimum
hour
embed
paraffin
section
prepar
bone
present
tissu
muscl
nasal
caviti
spinal
cord
tissu
decalcifi
use
immunoc
decal
chemic
corp
tallman
ny
section
stain
hematoxylin
eosin
h
e
serial
section
save
immunohistochem
stain
see
immunohistochem
analysi
fix
serial
section
mous
tissu
mount
onto
slide
deparaffin
xylen
rehydr
seri
ethanol
solut
wash
deioniz
water
section
first
treat
peroxidas
block
solut
methanol
room
temperatur
minut
quench
endogen
peroxidas
section
pretreat
pro
k
enzym
dako
corp
carpinteria
ca
room
temperatur
minut
stain
use
mous
mous
polym
detect
system
biocar
medic
concord
ca
primari
antibodi
mous
antila
cross
viru
monoclon
antibodi
qed
bioscienc
inc
san
diego
ca
recogn
gn
glycoprotein
use
dilut
tunel
stain
detect
apoptosi
preform
use
colorimetr
tunel
system
promega
usa
madison
wi
section
pretreat
pro
k
enzym
provid
kit
dilut
pb
strepavidin
also
provid
kit
dilut
pb
detect
slide
steam
hydrat
pretreat
diva
solut
biocar
medic
concord
ca
minut
primari
antibodi
rabbit
antihuman
dako
corpor
carpentaria
ca
use
dilut
detect
system
standard
abc
kit
vector
laboratori
burlingam
ca
dab
chromogen
modifi
harri
hematoxylin
counterstain
detect
macrophag
antigen
express
cell
slide
stream
hydrat
citrat
buffer
minut
primari
antibodi
rat
atcc
mannasa
va
use
dilut
follow
biotinyl
goatantirat
igg
secondari
antibodi
develop
streptavidin
hrp
biocar
concord
ca
rhesu
monkey
inocul
pfu
biolog
clone
human
mosquito
lacv
viru
inocul
intramuscularli
n
subcutan
n
blood
sampl
collect
day
post
inocul
blood
chemistri
viru
titrat
neutral
antibodi
titrat
axillari
inguin
lymph
node
surgic
excis
day
post
inocul
viral
titer
fix
buffer
formalin
histopatholog
immunohistochem
analysi
monkey
observ
daili
clinic
diseas
determin
lacv
infect
low
dose
rhesu
monkey
n
inocul
pfu
subcutan
blood
sampl
collect
day
post
inocul
neutral
antibodi
titrat
neutral
antibodi
mous
monkey
serum
quantit
plaqu
reduct
neutral
assay
test
sera
heat
inactiv
minut
serial
dilut
begin
prepar
optimem
invitrogen
supplement
fb
gentamicin
human
albumin
talecri
biotherapeut
inc
research
triangl
park
nc
homolog
lacv
dilut
final
titer
pfuml
diluent
guinea
pig
complement
cambrex
bioscienc
walkersvil
inc
walkersvil
md
ad
equal
volum
serum
dilut
mix
well
serumviru
mixtur
incub
minut
ad
confluent
monolay
vero
cell
incub
hour
allow
viru
attach
cell
overlay
methylcellulos
incub
day
incub
overlay
remov
monolay
wash
twice
pb
stain
crystal
violet
allow
enumer
viru
plaqu
plaquereduct
neutral
titer
calcul
author
declar
compet
interest
rsb
perform
anim
studi
data
analysi
draft
manuscript
cmc
particip
mous
monkey
studi
cyf
particip
mous
studi
jmw
oversaw
patholog
provid
histopatholog
immunohistochem
data
brm
ssw
supervis
studi
particip
design
plan
author
read
approv
final
manuscript
